|
Prescription Drug Search
Product Request Form
Ampyra is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Ampyra becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about CancerDrugsDirect.com
List of countries where we can ship Ampyra:
- Albania
- Anguilla
- Barbados
- Belgium
- Cayman Islands
- Colombia
- Cook Islands
- Croatia
- El Salvador
- European Union
- Finland
- Grenada
- Guam
- Honduras
- Hong Kong
- Iceland
- India
- Ireland
- Jamaica
- Japan
- Korea, Republic of
- Korea, South
- Lebanon
- Liechtenstein
- Luxembourg
- Moldova, Republic of
- Morocco
- Netherlands
- Nicaragua
- Norway
- Peru
- Philippines
- Poland
- Portugal
- Saudi Arabia
- Singapore
- Sweden
- Switzerland
- Thailand
- United Kingdom, UK
Latest news releases on Ampyra:
64th American Academy of Neurology Annual Meeting - Business Wire
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today presented data showing that the increase in walking speed demonstrated by people with multiple sclerosis (MS) who responded to treatment with AMPYRA ® during three-month ...
Acorda Therapeutics Presents AMPYRA® Long-Term Safety and Efficacy Data at 64th American Academy of Neurology Annual Meeting - PharmiWeb
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today presented data showing that the increase in walking speed demonstrated by people with multiple sclerosis (MS) who responded to treatment with AMPYRA® during three-month Phase 3 clinical trials was also ...
Acorda Therapeutics Recognized as One of the Best Places to Work in New York State for Second Consecutive Year - Phramalive.com
Acorda markets AMPYRA ® (dalfampridine) Extended Release Tablets, 10 mg, in the United States as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an improvement in walking speed. AMPYRA is marketed outside ...
Specialty pharmacy utilization management proves effective - Yahoo Finance
In doing this, we found that a UM program could be effective for Acthar Gel use," said Gleason. In the first study, paid and rejected Ampyra pharmacy claims were analyzed among commercially insured, continuously enrolled patients during the six ...
Acorda Therapeutics Inc. Reports Operating Results (10-Q) - GuruFocus
The cost of Ampyra inventory is based on a percentage of net product sales of the product in the quarter shipped to Acorda by Alkermes or our alternative manufacturer. In a quarter when there is a price increase, such as the three-month period ended March ...
6 High-Growth Mid Caps Rated As Buy Or Better - Seekingalpha.com
It manufactures and commercializes VIVITROL for alcohol and opioid dependence; RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia; AMPYRA to improve walking in patients with multiple sclerosis ...
6 High-Growth Biotechnology Stocks With Great Liquidity - Seekingalpha.com
Its marketed products include Ampyra (dalfampridine), a potassium channel blocker for improving walking in patients with MS; and Zanaflex Capsules and Zanaflex tablets (tizanidine hydrochloride), a short-acting drug for the management of spasticity.
For Acorda Therapeutics, disaster recovery protects vital enterprise assets - IT-Analysis.com
We have two marketed drugs in the market right now, the most recent of which, Ampyra, helps people with multiple sclerosis walk better, and it has been a huge success. And that's the main reason we've been growing so much lately. Prior to virtualization ...
